MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank80
3Y CAGR+264.7%
5Y CAGR+224.2%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+264.7%/yr
Annual compound
5Y CAGR
+224.2%/yr
Recent acceleration
Percentile
P80
Within normal range
vs 5Y Ago
358.3x
Strong expansion
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.18+2912.9%
20240.01-15.7%
20230.01+91.0%
20220.00-99.8%
20211.55+311093.9%
20200.00-